









Mercados
/
Ações
/
nasdaq-cor
/

Cencora Inc

COR

290.050USD

+3.970+1.39%

Horário de mercado （ET）Cotações atrasadas em 15 min

56.21BValor de mercado

33.19P/L TTM



Cencora Inc

290.050

+3.970+1.39%

Visão Geral Empresa Serviços Financeiros

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Informações da empresa

Código da empresaCOR

Nome da EmpresaCencora Inc

Data de listagemMay 28, 1996

Fundado em2001

CEODr. Robert P. (Bob) Mauch, Ph.D.

Número de funcionários42000

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 28

Endereço1 West First Avenue

CidadeCONSHOHOCKEN

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal19428

Telefone16107277000

Sitehttps://www.cencora.com/

Código da empresaCOR

Data de listagemMay 28, 1996

Fundado em2001

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

309.91K

-0.64%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.71K

+0.31%

Mr. Dennis M. Nally

Independent Director

12.41K

+0.98%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

11.35K

-26.17%

Mr. Werner Baumann

Independent Director

2.90K

+4.51%

Dr. Lorence H. Kim, M.D.

Independent Director

957.00

+469.64%

Ms. Lori J. Ryerkerk

Independent Director

516.00

Ms. Lauren M. Tyler

Independent Director

Mr. Bennett S. Murphy

Senior Vice President, Investor Relations

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

309.91K

-0.64%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.71K

+0.31%

Mr. Dennis M. Nally

Independent Director

12.41K

+0.98%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

11.35K

-26.17%

Mr. Werner Baumann

Independent Director

2.90K

+4.51%

Detalhamento da receita

Sem dados

Sem dados

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: ter, 13 de mai

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

11.60%

BlackRock Institutional Trust Company, N.A.

5.68%

Walgreens Boots Alliance Inc

4.96%

T. Rowe Price Associates, Inc.

4.81%

State Street Global Advisors (US)

4.34%

Other

68.61%

Investidores

Proporção

The Vanguard Group, Inc.

11.60%

BlackRock Institutional Trust Company, N.A.

5.68%

Walgreens Boots Alliance Inc

4.96%

T. Rowe Price Associates, Inc.

4.81%

State Street Global Advisors (US)

4.34%

Other

68.61%

Tipos de investidores

Investidores

Proporção

Investment Advisor

50.01%

Investment Advisor/Hedge Fund

30.03%

Corporation

4.96%

Hedge Fund

3.74%

Research Firm

3.49%

Bank and Trust

2.18%

Pension Fund

2.13%

Family Office

1.19%

Family Office

1.17%

Other

1.09%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

2286

191.77M

98.94%

+24.57K

2025Q1

2293

192.45M

99.29%

-2.90M

2024Q4

2214

199.54M

103.03%

-6.12M

2024Q3

2134

200.05M

102.56%

+474.02K

2024Q2

2090

200.10M

100.34%

-7.14M

2024Q1

2068

201.37M

100.95%

-1.37M

2023Q4

1982

202.46M

101.40%

+179.01K

2023Q3

1885

197.70M

97.79%

-2.16M

2023Q2

1870

195.01M

96.41%

-1.88M

2023Q1

1823

192.70M

95.24%

-7.51M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

21.28M

10.98%

+51.74K

+0.24%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

11.01M

5.68%

+234.21K

+2.17%

Mar 31, 2025

Walgreens Boots Alliance Inc

9.62M

4.96%

-765.00K

-7.37%

Jun 09, 2025

T. Rowe Price Associates, Inc.

9.33M

4.81%

+724.11K

+8.41%

Mar 31, 2025

State Street Global Advisors (US)

8.41M

4.34%

+382.24K

+4.76%

Mar 31, 2025

Wellington Management Company, LLP

5.42M

2.8%

+363.40K

+7.18%

Mar 31, 2025

Boston Partners

5.41M

2.79%

+404.09K

+8.07%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.50M

2.32%

+177.32K

+4.10%

Mar 31, 2025

Capital Research Global Investors

2.91M

1.5%

+8.07K

+0.28%

Mar 31, 2025

JP Morgan Asset Management

2.87M

1.48%

-576.23K

-16.70%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: dom, 6 de jul

Nome

Proporção

VanEck Pharmaceutical ETF

5.4%

AdvisorShares Focused Equity ETF

5.19%

Invesco Dorsey Wright Healthcare Momentum ETF

4.64%

First Trust Consumer Staples Alphadex Fund

4.5%

VanEck Retail ETF

2.94%

First Trust Dorsey Wright Momentum & Low Vol ETF

2.9%

SEI Enhanced US Large Cap Momentum Factor ETF

2.71%

Adaptive Core ETF

2.43%

Invesco Bloomberg Pricing Power ETF

2.4%

iShares US Consumer Staples ETF

2.34%

Ver Mais

VanEck Pharmaceutical ETF

Proporção5.4%

AdvisorShares Focused Equity ETF

Proporção5.19%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporção4.64%

First Trust Consumer Staples Alphadex Fund

Proporção4.5%

VanEck Retail ETF

Proporção2.94%

First Trust Dorsey Wright Momentum & Low Vol ETF

Proporção2.9%

SEI Enhanced US Large Cap Momentum Factor ETF

Proporção2.71%

Adaptive Core ETF

Proporção2.43%

Invesco Bloomberg Pricing Power ETF

Proporção2.4%

iShares US Consumer Staples ETF

Proporção2.34%

Dividendo

Um total de 1.92B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Feb 05, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 03, 2025

Feb 14, 2025

Nov 06, 2024

COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

Jul 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024

Aug 09, 2024

Aug 26, 2024

Aug 09, 2024

May 01, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024

May 10, 2024

May 24, 2024

May 09, 2024

Jan 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024

Feb 09, 2024

Feb 26, 2024

Feb 08, 2024

Nov 02, 2023

COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Nov 27, 2023

Nov 10, 2023

Aug 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023

Aug 11, 2023

Aug 28, 2023

Aug 10, 2023

May 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023

May 12, 2023

May 30, 2023

May 11, 2023

Feb 01, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023

Feb 10, 2023

Feb 27, 2023

Feb 09, 2023

Nov 04, 2022

COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

